Feasibility Study of Adhera® Fatigue Digital Program for Patients With Long COVID-related Fatigue
ClinicalTrials.gov; 18/11/2022; TrialID: NCT05631171
Clinical Trial Register
| ICTRP | ID: ictrp-NCT05631171
ABSTRACT
Condition
Post-Acute COVID19 Syndrome;FatigueIntervention
Behavioral Adhera® Fatigue Digital ProgramPrimary outcome:
Health-related quality of life;Health-related quality of life;Health-related quality of life;Fatigue;Fatigue;Fatigue;Emotional wellness;Emotional wellness;Emotional wellnessCriteria
Inclusion Criteria
- Individuals over 18 years of age.
- With long COVID, according to the World Health Organization (WHO) consensus definition
- Having a history of fatigue symptoms
- Obtain a score between 4 and 10 on the question "By how much do you rate your fatigue
level from 0 to 10 in the last 7 days?", where 0 is no fatigue and 10 is the worst
fatigue imaginable
- Have an Android or iOS smartphone compatible with the intervention program.
- Agree to participate in the study and sign the informed consent form
- Willingness and availability to comply with all study guidelines and procedures
Exclusion Criteria
- Hospital admission during the period of study participation.
- Participation in another study with pharmacological treatment
- Patients who are not technologically literate or unable to use the mobile application.
- Known severe psychiatric illness or presence of relevant cognitive impairment, at the
discretion of the recruiting physician
- With mobility restrictions that limit the patient's ability to perform mild physical
activity
- Being pregnant
- Patients who do not understand or speak Catalan or Spanish.
Collection:
Clinical trial registers
Database:
ICTRP
Topics:
Long Covid
Year:
2022
Document Type:
Clinical Trial Register
Similar
MEDLINE
...
LILACS
LIS